Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,467,544
-
Share change
-
+2,073,666
-
Total reported value
-
$1,811,286,824
-
Put/Call ratio
-
121%
-
Price per share
-
$52.55
-
Number of holders
-
172
-
Value change
-
+$117,879,421
-
Number of buys
-
94
-
Number of sells
-
76
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2017
As of 30 Jun 2017 AERIE PHARMACEUTICALS INC - COM (AERI) had 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,467,544 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Foresite Capital Management III, LLC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., Foresite Capital Management II, LLC, and DEERFIELD MANAGEMENT CO.
This table shows 172 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.